MedTrace Logo

Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac)

NCT01565577 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2014-09-08

No results posted yet for this study

Summary

This study aims to estimate the vaccinal immunity four years after four doses of MenbVac in children aged 4-8 years.

Conditions

  • Vaccination With MenbVac

Interventions

BIOLOGICAL

MenbVac

Blood test

Sponsors & Collaborators

  • Direction Générale de la Santé, France

    collaborator OTHER

  • Institut Pasteur

    collaborator INDUSTRY

  • Dieppe

    collaborator UNKNOWN

  • University Hospital, Rouen

    lead OTHER

Principal Investigators

  • François Caron, Professor · CHU - Hôpitaux de Rouen

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-06-30
Completion
2012-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01565577 on ClinicalTrials.gov